March 17, 2010 - Researchers found a two-week break in radiation therapy for patients with stage I small cell lung cancer, who have gone through surgery, reduced patients' symptoms without adversely affecting cancer survival, reports the February issue of the Journal of Thoracic Oncology.

While the majority of lung cancer patients present with locally advanced or stage IV disease, the primary challenge in treating them is that most present with poor performance status, and the benefit of treatment may be doubtful because of poor tolerance to any form of therapy.

Palliative chest radiotherapy for lung malignancies has shown to be effective in relieving serious chest symptoms from tumor bleeding or mass effect on major airways, vessels and nerves. However, there is a lack of consensus for an optimal palliative RT regimen.

Researchers sought to assess the overall efficacy of split-course palliative chest RT for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen’s two-week break has on survival outcomes.

Investigators reviewed the records of 140 patients treated between 1995 and 2006, who were prescribed to an initial 25 Gy in 10 fractions through anterior-posterior/posterior-anterior beam arrangements. After two weeks of rest, selected patients were given an additional 10 Gy (anterior-posterior/posterior-anterior) followed by off-cord beams to a final dose of 50 to 62.5 Gy.

Symptomatic relief was observed in 52 to 84 percent of patients with durable palliation in 58 percent. The researchers observed: "The built-in two-week break allowed for selection of patients for high-dose palliative radiation and balanced treatment benefits with potential side effects. Cancer survival was not adversely affected by treatments in this population with mostly advanced disease." The researchers added that the two-week break may be an option for patients who cannot tolerate an uninterrupted course.

Reference: Metcalfe, Su K.; Milano, Michael T.; Bylund, Kevin; Smudzin, Therese; Rubin, Philip; Chen, Yuhchyau. Split-Course Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(2):185-190, February 2010.

For more information: journals.lww.com/jto/toc/2010/02000


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now